Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

281 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Caffeine as a protective factor in dementia and Alzheimer's disease.
Eskelinen MH, Kivipelto M. Eskelinen MH, et al. J Alzheimers Dis. 2010;20 Suppl 1:S167-74. doi: 10.3233/JAD-2010-1404. J Alzheimers Dis. 2010. PMID: 20182054
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study.
Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Kivipelto M, et al. BMJ. 2001 Jun 16;322(7300):1447-51. doi: 10.1136/bmj.322.7300.1447. BMJ. 2001. PMID: 11408299 Free PMC article.
Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study.
Kivipelto M, Helkala EL, Hänninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Kivipelto M, et al. Neurology. 2001 Jun 26;56(12):1683-9. doi: 10.1212/wnl.56.12.1683. Neurology. 2001. PMID: 11425934
Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.
Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H. Kivipelto M, et al. Ann Intern Med. 2002 Aug 6;137(3):149-55. doi: 10.7326/0003-4819-137-3-200208060-00006. Ann Intern Med. 2002. PMID: 12160362
Midlife income, occupation, APOE status, and dementia: a population-based study.
Anttila T, Helkala EL, Kivipelto M, Hallikainen M, Alhainen K, Heinonen H, Mannermaa A, Tuomilehto J, Soininen H, Nissinen A. Anttila T, et al. Neurology. 2002 Sep 24;59(6):887-93. doi: 10.1212/wnl.59.6.887. Neurology. 2002. PMID: 12297572
Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects.
Tervo S, Kivipelto M, Hänninen T, Vanhanen M, Hallikainen M, Mannermaa A, Soininen H. Tervo S, et al. Dement Geriatr Cogn Disord. 2004;17(3):196-203. doi: 10.1159/000076356. Epub 2004 Jan 20. Dement Geriatr Cogn Disord. 2004. PMID: 14739544
Serum testosterone levels in males with Alzheimer's disease.
Pennanen C, Laakso MP, Kivipelto M, Ramberg J, Soininen H. Pennanen C, et al. J Neuroendocrinol. 2004 Feb;16(2):95-8. doi: 10.1111/j.0953-8194.2004.01133.x. J Neuroendocrinol. 2004. PMID: 14763994 Clinical Trial.
Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex.
Qiu C, Kivipelto M, Agüero-Torres H, Winblad B, Fratiglioni L. Qiu C, et al. J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):828-33. doi: 10.1136/jnnp.2003.021493. J Neurol Neurosurg Psychiatry. 2004. PMID: 15145993 Free PMC article.
A voxel based morphometry study on mild cognitive impairment.
Pennanen C, Testa C, Laakso MP, Hallikainen M, Helkala EL, Hänninen T, Kivipelto M, Könönen M, Nissinen A, Tervo S, Vanhanen M, Vanninen R, Frisoni GB, Soininen H. Pennanen C, et al. J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):11-4. doi: 10.1136/jnnp.2004.035600. J Neurol Neurosurg Psychiatry. 2005. PMID: 15607988 Free PMC article.
281 results
Jump to page
Feedback